ACORDA THERAPEUTICS INC - NOTE 6.000%12/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q2 2024

Type / Class
Debt / NOTE 6.000%12/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACORDA THERAPEUTICS INC - NOTE 6.000%12/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2024 Q2 $0 $0 -$115,470,720 0
2024 Q1 $201,951,000 $115,470,720 56.99% 8
2023 Q4 $201,951,000 $115,433,492 53.35% 8
2023 Q3 $201,951,000 $121,411,134 -$27,750 58.75% 8
2023 Q2 $196,983,000 $132,004,529 63.71% 7
2023 Q1 $209,042,000 $132,385,997 +$18,924,498 62.85% 8
2022 Q4 $172,001,000 $115,299,997 -$22,523,000 63.5% 7
2022 Q3 $174,000,000 $129,840,000 74.99% 7
2022 Q2 $202,001,000 $145,733,000 +$22,443,211 74.27% 8
2022 Q1 $172,001,000 $130,132,998 -$23,892,735 75.78% 8
2021 Q4 $202,001,000 $161,578,000 80.5% 10
2021 Q3 $202,001,000 $162,382,000 -$846,478 80.45% 10
2021 Q2 $203,001,000 $149,403,143 -$1,102,493 73.64% 10
2021 Q1 $204,501,000 $148,111,143 +$148,111,143 72.15% 10